TAIPEI, July 13, 2022 /PRNewswire/ — Health2Sync, Asia’s leading digital chronic disease management platform, announced today that it is signing a Memorandum of Understanding (MOU) with AstraZeneca Taiwan to provide its first digital solution for chronic kidney disease (CKD) patients in Taiwan.
Health2Sync and AstraZeneca Taiwan to Kick off Digital Patient Management Programs for Chronic Kidney Diseases comes via ChinaTechNews.com.
DealShot: 14 Deals Reaching $135 Million With Yuexiu Industrial Fund, Gaocheng Capital And More
Global assets shaken by China market turmoil
China turns up heat on individuals using foreign websites
Beijing to moderate monetary policy to support growth
Chinese exporters say profits holding up despite slower volumes 
Chinese equities rally cools
TSMC invests in advanced equipment factories without stopping, orders are booming in the first half of the year Anue Juheng – Taiwan Stock News
Asia’s stock markets facing worst month in 2 years
Spectre of ‘Indo-Pacific Nato’ accelerates China’s decoupling from the west
The Art of the North Korean Deal